Projects per year
Fingerprint
Dive into the research topics where Alexander Parker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center
Wilkie, D. D. J. (PI), Behar-Horenstein, L. S. (CoPI), Mochona, B. B. (CoPI), Hughes-halbert, C. C. A. (CoPI), Webb, F. J. (CoPI), Lee, J. H. (CoPI), Lamba, J. (CoPI), Allen, J. J. M. (CoPI), Kaninjing, E. (CoPI), Flores-rozas, H. H. A. (CoPI), Lyon, D. E. (CoPI), O’Neal, L. T. J. (CoPI), Stern, M. M. C. (CoPI), Ezenwa, M. M. O. (CoPI), Odedina, F. (CoPI), Okunieff, P. (CoPI), Parker, A. (CoPI), Reams, R. R. (CoPI), Yoon, S. (CoPI), Schmittgen, T. D. (CoPI), Su, L. M. (CoPI), Rogers, S. S. C. (CoPI), Mohammed, S. (CoPI), Trevino, J. G. (CoPI), Flores-rozas, H. A. (CoPI), Yao, Y. (CoPI) & Huang, Y. Y. (CoPI)
9/17/18 → 8/31/26
Project: Research project
-
PLANNING AND EVALUATION CORE
Parker, A. (PI), Parker, A. A. S. (PI) & Behar-Horenstein, L. S. (PI)
9/18/18 → 8/31/23
Project: Research project
-
Design and Validation of a Biomarker-enhanced System to Predict RCC Progression
Parker, A. (PI)
7/1/10 → 8/31/17
Project: Research project
-
Tissue and Metabolomic Biomarkers of Recurrent Renal Cell Carcinoma
Parker, A. (PI)
Congressionally Directed Medical Research Programs
4/1/10 → 4/30/14
Project: Research project
-
Tissue and Metabolomic Biomarkers of Recurrent Renal Cell Carcinoma
Parker, A. (PI)
1/1/09 → 12/31/09
Project: Research project
-
Genetic Testing for APOL1 in Adults With Hypertension: The GUARDD-US Randomized Clinical Trial
Implementing Genomics in Practice (IGNITE) Pragmatic Trials Network, Mar 5 2026, In: JAMA Network Open. 9, 3, e260528.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction to: UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation (Cancers, (2021), 13, 7, (1566), 10.3390/cancers13071566)
Nelson, R. S., Seligson, N. D., Bottiglieri, S., Carballido, E., Cueto, A. D., Imanirad, I., Levine, R., Parker, A. S., Swain, S. M., Tillman, E. M. & Hicks, J. K., Nov 2024, In: Cancers. 16, 21, 3595.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature
Abdelbaky, S. B., Giacopelli, B., Rabe, K. G., Yamaguchi, K., Wu, Y. Z., Yan, H., Shanafelt, T. D., Parikh, S. A., Ding, W., Hampel, P. J., Brown, S., Cerhan, J. R., Vachon, C. M., Kay, N. E., Hanson, C. A., Parker, A. S., Braggio, E., Slager, S. L. & Oakes, C. C., Apr 25 2024, In: Blood. 143, 17, p. 1752-1757 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis
Kleinstern, G., Boddicker, N. J., O’Brien, D. R., Allmer, C., Rabe, K. G., Norman, A. D., Griffin, R., Yan, H., Ma, T., Call, T. G., Bruins, L., Brown, S., de Campos, C. B., Hanson, C. A., Leis, J. F., Ding, W., Vachon, C. M., Kay, N. E., Oakes, C. C. & Parker, A. S. & 8 others, , May 14 2024, In: Blood Advances. 8, 9, p. 2118-2129 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of Medicaid expansion with 2-year survival and time to treatment initiation in gastrointestinal cancer patients: A National Cancer Database study
Mobley, E. M., Chen, G., Xu, J., Edgar, L., Pather, K., Daly, M. C., Awad, Z. T., Parker, A. S., Xie, Z., Suk, R., Mathews, S. & Hong, Y. R., Dec 15 2023, In: Journal of Surgical Oncology. 128, 8, p. 1285-1301 17 p.Research output: Contribution to journal › Article › peer-review
Open Access